Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

5 results
Display

The Efficacy and Safety of a Tofacitinib in the Treatment of Active Ulcerative Colitis

Seo GS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study

Nishikawa , Hasegawa K, Yabuno A, Yoshida H, Yasuda M, Kozawa E, Fujiwara K

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Topical and Oral Voriconazole in the Treatment of Fungal Keratitis

Lee SJ, Lee JJ, Kim SD

We describe two patients with fungal keratitis refractory to standard antifungal therapy whose conditions were managed with voriconazole. The first case is a patient with endophthalmitis and corneal ulcer due...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study

Lee TY, Choi JS, Oh HC, Song TJ, Do JH, Cheon YK

BACKGROUND/AIMS: Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP). Combination therapy w ith ora l udenafil and aceclofenac may reduce the occurrence of post-ERCP pancreatitis by targeting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparative Study of Low Doses of Rosuvastatin and Atorvastatin on Lipid and Glycemic Control in Patients with Metabolic Syndrome and Hypercholesterolemia

Park JS, Kim YJ, Choi JY, Kim YN, Hong TJ, Kim DS, Kim KY, Jeong MH, Chae JK, Oh SK, Seong IW

BACKGROUND/AIMS: This multicenter, open-labeled, randomized trial was performed to compare the effects of rosuvastatin 10 mg and atorvastatin 10 mg on lipid and glycemic control in Korean patients with nondiabetic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr